Health

Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).

* This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. * DXVX is taking the lead in business development, with several companies in the due diligence stage, and additional deals are anticipated. SEOUL, South...

2025-08-18 21:00 1799

LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company

BEIJING, Aug. 18, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious d...

2025-08-18 20:00 2520

KELUN-BIOTECH ANNOUNCES 2025 INTERIM RESULTS

* Revenue reached approximately RMB950.4 million, with total commercial sales RMB309.8million, representing a significant increase in proportion * Research and development expenses was approximately RMB611.5 million * Loss for the period was RMB145.2 million; adjusted loss for the period[1] ...

2025-08-18 18:29 2301

India's leading healthcare network Manipal Hospitals welcomes India's leading cancer specialist Dr. Surender Kumar Dabas to strengthen robotic cancer care in Delhi NCR

NEW DELHI, Aug. 18, 2025 /PRNewswire/ -- Manipal Hospitals, one of India's leading and globally recognized healthcare institutions, welcomes one ofIndia's most renowned robotic oncosurgeons, Dr. Surender Kumar Dabas

2025-08-18 18:23 1409

GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies

YONGIN, South Korea, Aug. 18, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a South Korean biopharmaceutical company, announced today that it has signed a Memorandum of Understanding (MOU) with the Thai Red Cross Society (TRCS) to cooperate on workforce training for the production of plasma-deri...

2025-08-18 12:40 1514

Next Generation Refractive Surgery to LASIK and SMILE Now Available for Clinical Review

Pioneer surgeon Dr Natasha Lim is among the first in Singapore to offer Smooth Incision Lenticular Keratomileusis (SILK) procedure in their clinics. SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- Dr. Natasha Lim, an internationally renowned surgeon in Ophthalmology, has introduced an alternative to est...

2025-08-18 11:00 1686

Herbalgy, Pain Management Expert, Harnesses the Wisdom of Traditional Chinese Medicine to Safeguard Hong Kong's Health, Proudly Appoints Moses Chan as Brand Ambassador

Download high-resolution images: https://cutt.ly/IrGBefFJ HONG KONG, Aug. 18, 2025 /PRNewswire/ -- As Hong Kong's pain management expert, Herbalgy has been serving the community since its founding in 1999. For over 25 years, the brand has been dedicated to promoting he...

2025-08-18 10:00 1710

New support group to provide social and community support for neurofibromatosis patients

Co-founded by individuals living with this rare genetic condition, the  Neurofibromatosis Society Singapore seeks to close gaps in mental and emotional care SINGAPORE, Aug. 18, 2025 /PRNewswire/ -- A new patient-led support group, the Neurofibromatosis Society (NFS)Singapore, has been recently re...

2025-08-18 09:00 1780

Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity

-  Combination of a low dose of ASC47 with ASC31, a novel peptide agonist targeting bothGLP-1 receptor (GLP-1R) and GIP receptor (GIPR), resulted in a 44.8% reduction in body weight after 14 days of treatment in a diet-induced obese (DIO) mouse model. -  Combination of a low dose of ASC47 with A...

2025-08-18 08:15 1784

GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation

Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the ...

2025-08-17 20:01 2307

VARON's Lung Health Awareness Initiative Urges Proactive Steps for Allergy and Flu this Fall Season

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- With allergy and flu season approaching, VARON  is calling on individuals to take preventive measures to protect their lungs. Through its"Every Breath Counts" i...

2025-08-15 23:08 2477

BestQool Announces Summer Promotion and Fall Refresh with New Logo and BQ60Pro Preview

Summer Appreciation Sales Offers 12% Off All Products NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer of home-use red light therapy devices, is excited to unv...

2025-08-15 21:00 2539

Tie "James" Li, Chairman of NMHI, To Speak at XRP Seoul 2025 Global Conference

ONTARIO, Calif., Aug. 15, 2025 /PRNewswire/ -- Tie "James" Li, Chairman and CEO of Nature's Miracle Holding Inc. (OTCQB:NMHI) will attend the XRP Seoul 2025 Global Conference as a keynote speaker onSeptember 21, 2025. XRP SEOUL 2025 hosted by XRPL Korea is a global conference bringing together ...

2025-08-15 20:30 3044

Novel Gene Therapy for ALS cleared for global trials in China and the U.S.

BEIJING, Aug. 15, 2025 /PRNewswire/ -- SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, announced today thatChina's National Medical Products Administration (NMPA) has cleared the Investigational...

2025-08-15 19:00 1793

Saigon Technology Drives Industry-Specific AI Transformation, Moving Businesses Beyond SaaS Limitations

Vietnamese software leader leverages AI and domain expertise to help industries modernize workflows and reduce long-term tech costs. HO CHI MINH CITY, Vietnam, Aug. 15, 2025 /PRNewswire/ -- As global businesses outgrow generic SaaS tools, Saigon Technology is delivering next-gen, AI-powered cust...

2025-08-15 10:00 1799

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

Shanghai, Aug. 15, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that etrasimod (VELSIPITY®) has be...

2025-08-15 09:35 2061

CARsgen Therapeutics Announces 2025 Interim Results

SHANGHAI, Aug. 14, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2025 Interim Results. Business Highlights * Cash and bank balances were around RMB1,261 million as of June 30,...

2025-08-15 08:15 2707

TraceLink Accelerates Supply Chain Transformation with New OPUS Platform Capabilities for an AI-Powered Future

BOSTON, Aug. 14, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the life sciences and healthcare supply chain, today announced significant new platform enhancements to drive supply chain transformation with itsOrchestration Platfor...

2025-08-14 22:00 1863

Sisram Medical will Report H1 2025 Financial Results on August 20 and Hold a Conference Call on August 21

H1 2025 conference call to be held on August 21, at 8:30 a.m. Eastern Time HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred to as the "Group"), a global consumer wellness group featuring a first-of...

2025-08-14 20:00 2097

Leads Biolabs Announces Completion of Patient Enrollment in Pivotal Trial of Opamtistomig Monotherapy for Extrapulmonary Neuroendocrine Carcinoma

NANJING, China, Aug. 14, 2025 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the successful completion of patient enrollment in the ongoing single-arm, pivotal registrational clinical trial (CTR20213023) for Opamtistomig (LB...

2025-08-14 17:38 2141
1 ... 67686970717273 ... 872